SciCombinator

Discover the most talked about and latest scientific content & concepts.

Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018

OPEN MMWR. Morbidity and mortality weekly report | 9 Aug 2019

GP Guy, TM Haegerich, ME Evans, JL Losby, R Young and CM Jones
Abstract
The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 morphine milligram equivalents per day [high-dose], and concurrent use of benzodiazepines). In light of the high numbers of drug overdose deaths involving opioids, 36% of which in 2017 involved prescription opioids, improving access to naloxone is a public health priority. CDC examined trends and characteristics of naloxone dispensing from retail pharmacies at the national and county levels in the United States.
Tweets*
75
Facebook likes*
3
Reddit*
0
News coverage*
26
Blogs*
5
SC clicks
0
Concepts
-
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com